Safety of meloxicam oral provocation challenge in patients with NSAID reaction

Morales, C; Villa, Ricardo Cardona; Henao, Catalina María Gómez; Gómez, Luisa María Holguín; Giraldo, Ruth Elena Ramírez; Mejia, Carlos Fernando Chinchilla; Zuluaga, Laura

doi:10.1186/1939-4551-8-s1-a265

Cited by 1 publication

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…El asma puede tener otros exacerbantes, por lo cual se debe garantizar el uso continuo del tratamiento controlador. Además, al paciente se le debe ofrecer alternativas analgésicas seguras a través de pruebas de provocación, 43 como acetaminofén (< 1000 mg), inhibidores parciales de COX (meloxicam, nimesulida) o inhibidores selectivos de la COX-2(cuadro 3). 7,39,44.45,46 Antes de la polipectomía es necesario que el paciente haya recibido tratamiento farmacológico, 32,47 que comprende lavados nasales, esteroides tópicos y en ocasiones ciclos cortos de esteroides orales.…”

Section: Manejounclassified

Enfermedad respiratoria exacerbada por aspirina. Revisión a partir de casos clínicos

Hernández-Moreno

Cardona

2018

RAM

View full text Add to dashboard Cite

Aspirin-exacerbated respiratory disease comprises a series of signs and symptoms mainly involving the upper and lower posterior airway after the consumption of cyclooxygenase enzyme inhibitors. Adverse reactions that occur are not considered to be an allergy and are common to all non-steroidal anti-inflammatory drugs, and cross-reactivity between these agents is therefore common. The description of 3 clinical cases serves to review key aspects of this condition, such as epidemiology, pathophysiology, clinical manifestations, diagnosis and management. Adequate diagnosis and education on the use or elimination of all different NSAIDs is essential, as well as availability of different analgesic options, verified with challenge tests. Aspirin-exacerbated respiratory disease management includes surgical procedures for nasal polyp control, pharmacological treatment for asthma control and desensitization with aspirin in selected individuals.

show abstract

Section: Manejounclassified

Enfermedad respiratoria exacerbada por aspirina. Revisión a partir de casos clínicos

Hernández-Moreno

Cardona

2018

RAM

View full text Add to dashboard Cite

show abstract

Safety of meloxicam oral provocation challenge in patients with NSAID reaction

Cited by 1 publication

References 2 publications

Enfermedad respiratoria exacerbada por aspirina. Revisión a partir de casos clínicos

Enfermedad respiratoria exacerbada por aspirina. Revisión a partir de casos clínicos

Contact Info

Product

Resources

About